Federal Register / Vol. 83, No. 115 / Thursday, June 14, 2018 / Notices 27781 

EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Form name 

Number of 

respondents/ 

POCs 

Number of 

responses per 

POC 

Hours per 

response 

Total burden 

hours 

Total .......................................................................................................... NA NA NA 121 

EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN

Form name 

Number of 

respondents/ 

POCs 

Total burden 

hours 

Average 

hourly wage 

rate * 

Total cost 

burden 

Eligibility and Registration Form ...................................................................... 100 8 $45.23 $361.84 

Data Use Agreement ....................................................................................... 100 5 45.23 226.15 

ASC Site Information ....................................................................................... 100 8 45.23 361.84 

Data Files Submission ..................................................................................... 100 100 45.23 4,523.00 

Total .......................................................................................................... NA 121 45.23 5,472.83 

* Based on the mean hourly wage for 100 ASC Administrative Services Managers (11–3011; $45.23) obtained from the May 2016 National Industry-Specific Occupational Employment and Wage Estimates: NAICS 621400—Outpatient Care Centers (located at http://www.bls.gov/oes/current/naics4_621400.htm#11-0000). 

Request for Comments 

In accordance with the Paperwork 

Reduction Act, comments on AHRQ’s 

information collection are requested 

with regard to any of the following: (a) 

Whether the proposed collection of 

information is necessary for the proper 

performance of AHRQ’s health care 

research and health care information 

dissemination functions, including 

whether the information will have 

practical utility; (b) the accuracy of 

AHRQ’s estimate of burden (including 

hours and costs) of the proposed 

collection(s) of information; (c) ways to 

enhance the quality, utility and clarity 

of the information to be collected; and 

(d) ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Francis D. Chesley, Jr., 

Acting Deputy Director. 

[FR Doc. 2018–12767 Filed 6–13–18; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2018–0057] 

Notice of Intent To Prepare an 

Environmental Impact Statement, 

Public Scoping Meeting, and Request 

for Comments; Acquisition of Site for 

Development of a Replacement 

Underground Safety Research 

Program Facility for the Centers for 

Disease Control and Prevention/ 

National Institute for Occupational 

Safety and Health (CDC/NIOSH) in 

Mace, West Virginia 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS) 

ACTION: Notice of intent; announcement 

of public meeting; and request for 

comments. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) within 

the Department of Health and Human 

Services (HHS), in cooperation with the 

General Services Administration (GSA), 

announces its intent to prepare an 

Environmental Impact Statement (EIS) 

to analyze and assess the environmental 

impacts of the proposed acquisition of 

a site in Mace, West Virginia, and the 

development of this site into a 

replacement of the National Institute for 

Occupational Safety and Health 

(NIOSH) Underground Safety Research 

Program facility (Proposed Action). The 

current acquisition and development 

would replace the former Lake Lynn 

Experimental Mine in Fayette County, 

Pennsylvania and would support 

research programs focused on miner 

health and safety issues. The site being 

considered for acquisition and 

development includes 461.35 acres 

located off of U.S. Route 219 in 

Randolph and Pocahontas Counties near 

Mace, West Virginia. 

This notice is pursuant to the 

requirements of the National 

Environmental Policy Act of 1969 

(NEPA) as implemented by the Council 

on Environmental Quality (CEQ) 

Regulations (40 CFR parts 1500–1508). 

CDC, in cooperation with GSA, also 

intends to initiate consultation, as 

required by Section 106 of the National 

Historic Preservation Act (NHPA), to 

evaluate the potential effects, if any, of 

the Proposed Action on historic 

properties. Following the scoping 

meeting, a Draft EIS will be prepared 

and circulated for public comment. CDC 

is the lead federal agency for this 

Proposed Action. 

DATES: 

Public Scoping Meeting: A public 

scoping meeting in open house format 

will be held on June 26, 2018 in 

Slatyfork, West Virginia. The meeting 

will begin at 5:30 p.m. and end no later 

than 8:30 p.m. 

Written comments: Written scoping 

comments must be submitted by 11:59 

p.m. on July 14, 2018. 

Deadline for Requests for Special 

Accommodations: Persons wishing to 

participate in the public scoping 

meeting who need special 

accommodations should contact Sam 

Tarr at 770–488–8170 by 5:00 p.m. 

Eastern Time, June 19, 2018. 

ADDRESSES: The public scoping meeting 

will be held at the Linwood Community 

Library, 72 Snowshoe Drive, Slatyfork, 

West Virginia 26291. 


daltland on DSKBBV9HB2PROD with NOTICES
27782 Federal Register / Vol. 83, No. 115 / Thursday, June 14, 2018 / Notices 

You may submit comments identified 

by Docket No. CDC–2018–0057 by either 

of the following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov (Follow the 

instructions for submitting comments). 

• U.S. Mail: Sam Tarr, Office of 

Safety, Security, and Asset Management 

(OSSAM), Centers for Disease Control 

and Prevention, 1600 Clifton Road NE, 

MS–K80, Atlanta, Georgia 30329–4027. 

Instructions: All submissions must 

include the agency name and Docket 

Number. All relevant comments 

received will be posted to http://

www.regulations.gov (personally 

identifiable information, except for first 

and last names, will be redacted). For 

access to the docket to review 

background documents or comments 

received, go to http://

www.regulations.gov. 

FOR FURTHER INFORMATION CONTACT: Sam 

Tarr, Office of Safety, Security, and 

Asset Management (OSSAM), Centers 

for Disease Control and Prevention, 

1600 Clifton Road NE, MS–K80, Atlanta, 

Georgia 30329–4027, phone: (770) 488– 

8170, or email: cdc-macewv-eis@

cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: CDC is dedicated to 

protecting health and promoting quality 

of life through the prevention and 

control of disease, injury, and disability. 

NIOSH, one of CDC’s Centers, Institutes, 

and Offices, was established by the 

Occupational Safety and Health Act of 

1970. NIOSH plans, directs, and 

coordinates a national program to 

develop and establish recommended 

occupational safety and health 

standards, conduct research and 

training, provide technical assistance, 

and perform related activities to ensure 

safe and healthful working conditions 

for every working person in the United 

States. 

In 1997, NIOSH assumed the lease for 

a facility referred to as the Lake Lynn 

Experimental Mine (LLEM) when the 

mine safety and health function was 

transferred from the Bureau of Mines 

(BOM) to NIOSH. The LLEM facility had 

been leased by BOM since 1982. The 

LLEM was located 60 miles south of 

Pittsburgh, Pennsylvania. The LLEM 

and above ground fire testing facility 

was primarily used for studies and 

research on mine explosions, mine 

seals, mine rescue, ventilation, diesel 

exhaust, new health and safety 

technologies, ground control, and fire 

suppression. After December 2012, the 

property was no longer available for 

long-term leasing. CDC attempted to 

purchase the LLEM underlying 

property, but LLEM was vacated by the 

Government after market-based 

purchase offers were rejected by the 

property owners. 

In 2013, CDC completed a Project 

Development Study to outline a design 

solution for the replacement of the 

LLEM. The study presented the facility 

and site requirements and design 

concepts for the replacement facilities. 

In 2016, to identify potentially available 

locations that could accommodate the 

space requirements defined in the 2013 

study, GSA issued (on behalf of CDC) 

two separate Request for Expressions of 

Interest (REOI) for a site, developed or 

undeveloped, that could be used for the 

new underground safety research 

facility. The first REOI, advertised in 

June 2016, contained a limited 

delineated area within a 200-mile radius 

of the LLEM. The REOI set forth criteria 

that would be used to evaluate the 

suitability of the submitted sites. One 

expression of interest that had the 

potential to meet the minimum criteria 

was received. After further evaluation, 

however, the site was found to be nonviable. 

The second REOI was issued in 

October 2016 and expanded the 

delineated area to the contiguous United 

States. Three expressions of interest 

were received. One did not meet the 

minimum criteria, and a second 

expression of interest did not contain all 

necessary information to evaluate the 

offer. The offeror of the second site did 

not respond to subsequent GSA 

inquiries. 

The third potential site met the 

minimum criteria and was determined 

to be a viable site. The site is located 

near Mace, West Virginia, and straddles 

the Randolph and Pocahontas County 

lines. 

In accordance with NEPA, as 

implemented by the CEQ regulations (40 

CFR parts 1500–1508), CDC is initiating 

the preparation of an EIS for the 

proposed acquisition of the site and 

construction of a new underground 

safety research facility on the Site. 

Under NEPA, Federal agencies are 

required to evaluate the environmental 

effects of their proposed actions and a 

range of reasonable alternatives to the 

proposed action before making a 

decision. At a minimum, the EIS will 

evaluate the following two alternatives: 

The Proposed Action Alternative 

(acquisition of the Site and construction 

of a new underground safety research 

facility) and the No Action Alternative. 

Scoping Process: In accordance with 

NEPA, a public scoping process will be 

conducted to establish the range of 

issues to be addressed during the 

preparation of the EIS. Scoping is an 

early and open process for determining 

the scope of issues to be addressed and 

identifying issues that should be taken 

into account in selecting an alternative 

for implementation. To that end, during 

the scoping process, CDC will actively 

seek input from interested people; 

organizations; federally recognized 

Native American tribes; and federal, 

state, and regional agencies. 

The purpose of this Notice is to 

inform interested parties regarding 

CDC’s plan to prepare an EIS for the 

proposed Site acquisition in Mace, West 

Virginia, and the development of the 

Site into an underground safety research 

facility; to provide information on the 

nature of the Proposed Action; and to 

initiate the scoping process. The public 

scoping meeting will be held on June 

26, 2018, at the Linwood Community 

Library, 72 Snowshoe Drive, Slatyfork, 

West Virginia 26291, from 5:30 p.m. to 

8:30 p.m. Eastern Time. The public 

scoping meeting will be in open house 

format. General information on the Site 

and the Proposed Action will be 

provided, and representatives of CDC 

and GSA will be available to answer 

one-on-one questions. There will be no 

formal presentation or question-andanswer session. Participants may arrive 

at any time between 5:30 p.m. and 8:30 

p.m. Eastern Time. Comment forms will 

be provided for written comments, and 

a stenographer will be available to 

transcribe oral comments. Through the 

NEPA scoping process, CDC will also 

facilitate consultation with the public as 

required by Section 106 of the NHPA. 

Dated: June 7, 2018. 

Sandra Cashman, 

Executive Secretary Centers for Disease 

Control and Prevention. 

[FR Doc. 2018–12660 Filed 6–13–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2018–D–1918] 

Human Immunodeficiency Virus-1 

Infection: Developing Systemic Drug 

Products for Pre-Exposure 

Prophylaxis; Draft Guidance for 

Industry; Availability 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of availability. 

SUMMARY: The Food and Drug 

Administration (FDA or Agency) is 

announcing the availability of a draft 

guidance for industry entitled ‘‘Human 

Immunodeficiency Virus-1 Infection: 

Developing Systemic Drug Products for 


daltland on DSKBBV9HB2PROD with NOTICES